Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (11)

1

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma : A phase 1/2 study

enthalten in: Cancer medicine | 2023

von Lesokhin, A. | LeBlanc, R. | Dimopoulos, M. | +18

2

BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas

enthalten in: Nature communications | 2023

von Moreno, V. | Vieito, M. | Sepulveda, J. | +18

3

A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma

enthalten in: Hematological oncology | 2023

von Carlo-Stella, C. | Zinzani, P. | Sureda, A. | +22

4

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

5

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma : A Phase I Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Hutchings, M. | Morschhauser, F. | Iacoboni, G. | +20

CommentIn: Nat Rev Clin Oncol. 2021 May;18(5):257. - PMID 33828233

6

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

enthalten in: Blood | 2021

von Hamadani, M. | Radford, J. | Carlo-Stella, C. | +14

CommentIn: Blood. 2021 May 13;137(19):2568-2570. - PMID 33983420

7

A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies : Results From the European Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Carlo-Stella, C. | Delarue, R. | Scarfo, L. | +8

8

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kahl, B. | Hamadani, M. | Radford, J. | +12

9

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery

enthalten in: Blood | 2009

von Dodero, A. | Carniti, C. | Raganato, A. | +10

10

Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination : a phase I trial in metastatic melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2004

von Di Nicola, M. | Carlo-Stella, C. | Mortarini, R. | +11